IRME (IR-Med) FCF Margin %: 0.00% (As of Jun. 2025)


What is IR-Med FCF Margin %?

IR-Med IRME FCF Margin % is 0.00% as of Jun. 2025. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, IR-Med ranks worse than 122699.26% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. IR-Med's Free Cash Flow for the three months ended in Jun. 2025 was $-0.07 Mil. IR-Med's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. Therefore, IR-Med's FCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, IR-Med's current FCF Yield % is -108.70%.

The historical rank and industry rank for IR-Med's FCF Margin % or its related term are showing as below:


IRME's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.1
* Ranked among companies with meaningful FCF Margin % only.

IR-Med FCF Margin % Related Terms

IR-Med FCF Margin % Historical Data

* Premium members only.

The historical data trend for IR-Med's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IR-Med FCF Margin % Chart

IR-Med Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
0.00 0.00 0.00 0.00 0.00

IR-Med Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IRME vs SSKN, NUMD, WOK: FCF Margin % Comparison

For the Medical Devices subindustry, IR-Med's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IR-Med FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IR-Med's FCF Margin % distribution charts can be found below:

* The bar in red indicates where IR-Med's FCF Margin % falls into.


IR-Med FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

IR-Med's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-1.386/0
= %

IR-Med's FCF Margin for the quarter that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.071/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
IR-Med (IRME) has a FCF Margin % of 0.00% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IR-Med and its competitors. According to the industry distribution chart, IR-Med ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is IR-Med's FCF Margin % too high?
IR-Med's current FCF Margin % is 0.00%. Based on the distribution chart, IR-Med ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does IR-Med's FCF Margin % compare to SSKN and NUMD?
According to the Medical Devices & Instruments industry distribution chart, IR-Med ranks #999999 out of 815 companies for FCF Margin %. This places IR-Med in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IR-Med and its competitors. IR-Med's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IR-Med stock overvalued right now?
IR-Med (IRME) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For IR-Med (IRME), the current FCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IR-Med Business Description

Address Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400
IR-Med Inc is a development-stage medical device company that is developing its technology through its Subsidiary and utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology to develop non-invasive devices for various medical indications. These devices detect and measure biomarkers and molecules in blood and human tissue in real-time.